Current Journal of Neurology

Embryonic stem cell-derived neural stem cell transplantation in experimental ischemic stroke: A systematic review and meta-analysis

Document Type : Review Article

Authors

Narges Saadatipour 1
Hamed Zarei 1
Alireza Ghorbani 1
Amirmohammad Toloui 1
Arian Madani-Neishaboori 1
Ahmad Madankan 2
Arash Sarveazad 3
Mahmoud Yousefifard 1

1 Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran

2 Department of General Surgery, Rasool-E Akram Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran

3 Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran Nursing Care Research Center, Iran University of Medical Sciences, Tehran, Iran

https://doi.org/10.18502/cjn.v24i4.22681
Abstract
Background: Stem cell therapy holds promise for neural repair after ischemic injury. This systematic review and meta-analysis evaluated the efficacy of embryonic stem cell-derived neural stem/progenitor cells (ESC-NSCs) in experimental ischemic stroke.
Methods: Preclinical animal studies were identified through MEDLINE, Embase, Scopus, and Web of Science by February 2024. Screening, data extraction, and risk-of-bias assessment (SYRCLE tool) were performed independently by two reviewers.
Results: Twenty-three studies met inclusion criteria. Pooled analyses indicated that ESC-NSC transplantation improved locomotion [standardized mean difference (SMD) = 0.57; 95% confidence interval (CI): 0.34 to 0.80; P < 0.001] and neurological status assessed by the cylinder test (SMD = 0.69; 95% CI: 0.29 to 1.08; P = 0.001), while reducing infarct volume (SMD = -0.26; 95% CI: -0.50 to -0.02; P = 0.030) and astrocytosis [glial fibrillary acidic protein (GFAP)⁺ cells; SMD = -3.02; 95% CI: -3.87 to -2.18; P < 0.001]. 
No significant effect was observed on inflammation [ionizing calcium-binding adaptor molecule 1 (Iba-1)⁺ cells; SMD = -3.69; 95% CI: -10.03 to 2.64; P = 0.254]. Subgroup analyses showed greater locomotor improvement when ESC-NSCs were administered 24-72 hours after stroke, in both neonatal and adult models. Most included studies had an unclear risk of bias in randomization and blinding domains. According to Grading of Recommendations Assessment, Development, and Evaluation (GRADE), the certainty of evidence was low to moderate for the main outcomes.
Conclusion: ESC-NSC transplantation may enhance locomotor and neurological recovery and reduce tissue damage in experimental ischemic stroke, particularly when administered in the early post-ischemic phase. However, due to methodological heterogeneity, small sample sizes, and low-to-moderate certainty of evidence, these findings should be interpreted with caution.

Keywords

Neural Stem Cells
Embryonic Stem Cells
Stroke Rehabilitation
Neurodegenerative Diseases
Cerebral Infarction
Subjects
  1. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the global burden of disease study 2019. The Lancet Neurology 2021; 20(10): 795-820.
  2. Zheng H, Zhang B, Chhatbar PY, Dong Y, Alawieh A, Lowe F, et al. Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research. Cell Transplant 2018; 27(12): 1723-30.
  3. Laskowitz DT, Bennett ER, Durham RJ, Volpi JJ, Wiese JR, Frankel M, et al. Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. Stem Cells Transl Med 2018; 7(7): 521-9.
  4. Martínez-Garza DM, Cantú-Rodríguez OG, Jaime-Pérez JC, Gutiérrez-Aguirre CH, Góngora-Rivera JF, Gómez-Almaguer D. Current state and perspectives of stem cell therapy for stroke. Medicina Universitaria 2016; 18(72): 169-80.
  5. Nagpal A, Choy FC, Howell S, Hillier S, Chan F, Hamilton-Bruce MA, et al. Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis. Stem Cell Res Ther 2017; 8(1): 191.
  6. Huang L, Wong S, Snyder EY, Hamblin MH, Lee JP. Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury. Stem Cell Res Ther 2014; 5(6): 129.
  7. Ji X, Zhou Y, Gao Q, He H, Wu Z, Feng B, et al. Functional reconstruction of the basal ganglia neural circuit by human striatal neurons in hypoxic-ischaemic injured brain. Brain 2023; 146(2): 612-28.
  8. Li K, Peng L, Xing Q, Zuo X, Huang W, Zhan L, et al. Transplantation of hESCs-Derived Neural Progenitor Cells Alleviates Secondary Damage of Thalamus After Focal Cerebral Infarction in Rats. Stem Cells Transl Med 2023; 12(8): 553-68.
  9. Z Zhang RL, Chopp M, Gregg SR, Toh Y, Roberts C, Letourneau Y, et al. Patterns and dynamics of subventricular zone neuroblast migration in the ischemic striatum of the adult mouse. J Cereb Blood Flow Metab 2009; 29(7): 1240-50.
  10. Jin K, Sun Y, Xie L, Peel A, Mao XO, Batteur S, et al. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 2003; 24(1): 171-89.
  11. Arab L, Fanni A, Nemati S, Arefian E, Farahmandfar M, Aghdami N, et al. Human embryonic derived neural progenitor cells improves neurological scores following brain ischemia/reperfusion: Modulation of blood and brain tissue MicroRNA-210. J Contemp Med Sci 2020; 6(3): 103-8.
  12. Hamblin MH, Murad R, Yin J, Vallim G, Lee JP. Modulation of gene expression on a transcriptome-wide level following human neural stem cell transplantation in aged mouse stroke brains. Exp Neurol 2022; 347: 113913.
  13. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
  14. Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol 2014; 14: 43.
  15. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ 2008; 336(7651): 995-8.
  16. Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods 2010; 1(2): 112-25.
  17. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7(8): 889-94.
  18. Baujat B, Mahé C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med 2002; 21(18): 2641-52.
  19. D Doleman B, Freeman SC, Lund JN, Williams JP, Sutton AJ. Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. Res Synth Methods 2020; 11(4): 522-34.
  20. Chang DJ, Oh SH, Lee N, Choi C, Jeon I, Kim HS, et al. Contralaterally transplanted human embryonic stem cell-derived neural precursor cells (ENStem-A) migrate and improve brain functions in stroke-damaged rats. Exp Mol Med 2013; 45(11): e53.
  21. Daadi MM, Maag AL, Steinberg GK. Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One 2008; 3(2): e1644.
  22. Daadi MM, Davis AS, Arac A, Li Z, Maag AL, Bhatnagar R, et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010; 41(3): 516-23.
  23. Daadi MM, Hu S, Klausner J, Li Z, Sofilos M, Sun G, et al. Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant 2013; 22(5): 881-92.
  24. Drury-Stewart D, Song M, Mohamad O, Guo Y, Gu X, Chen D, et al. Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice. Stem Cell Res Ther 2013; 4(4): 93.
  25. Fujimoto M, Hayashi H, Takagi Y, Hayase M, Marumo T, Gomi M, et al. Transplantation of telencephalic neural progenitors induced from embryonic stem cells into subacute phase of focal cerebral ischemia. Lab Invest 2012; 92(4): 522-31.
  26. Guan Y, Zou H, Chen X, Zhao C, Wang J, Cai Y, et al. Ischemia, immunosuppression, and SSEA-1-negative cells all contribute to tumors resulting from mouse embryonic stem cell-derived neural progenitor transplantation. J Neurosci Res 2014; 92(1): 74-85.
  27. Hayashi J, Takagi Y, Fukuda H, Imazato T, Nishimura M, Fujimoto M, et al. Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab 2006; 26(7): 906-14.
  28. Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci 2009; 29(3): 562-74.
  29. Islam R, Drecun S, Varga BV, Vonderwalde I, Siu R, Nagy A, et al. Transplantation of Human Cortically-Specified Neuroepithelial Progenitor Cells Leads to Improved Functional Outcomes in a Mouse Model of Stroke. Front Cell Neurosci 2021; 15: 654290.
  30. Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y, et al. Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab 2010; 30(3): 534-44.
  31. Jin K, Mao X, Xie L, Greenberg RB, Peng B, Moore A, et al. Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats. Aging Cell 2010; 9(6): 1076-83.
  32. Kim HS, Choi SM, Yang W, Kim DS, Lee DR, Cho SR, et al. PSA-NCAM(+) neural precursor cells from human embryonic stem cells promote neural tissue integrity and behavioral performance in a rat stroke model. Stem Cell Rev Rep 2014; 10(6): 761-71.
  33. Patkar S, Uwanogho D, Modo M, Tate RJ, Plevin R, Carswell HVO. Targeting 17β-estradiol biosynthesis in neural stem cells improves stroke outcome. Front Cell Neurosci 2022; 16: 917181.
  34. Rosenblum S, Smith TN, Wang N, Chua JY, Westbroek E, Wang K, et al. BDNF Pretreatment of Human Embryonic-Derived Neural Stem Cells Improves Cell Survival and Functional Recovery After Transplantation in Hypoxic-Ischemic Stroke. Cell Transplant 2015; 24(12): 2449-61.
  35. Shabani Z, Rahbarghazi R, Karimipour M, Ghadiri T, Salehi R, Sadigh-Eteghad S, et al. Transplantation of bioengineered Reelin-loaded PLGA/PEG micelles can accelerate neural tissue regeneration in photothrombotic stroke model of mouse. Bioeng Transl Med 2022; 7(1): e10264.
  36. Shinoyama M, Ideguchi M, Kida H, Kajiwara K, Kagawa Y, Maeda Y, et al. Cortical region-specific engraftment of embryonic stem cell-derived neural progenitor cells restores axonal sprouting to a subcortical target and achieves motor functional recovery in a mouse model of neonatal hypoxic-ischemic brain injury. Front Cell Neurosci 2013; 7: 128.
  37. Somaa FA, Wang TY, Niclis JC, Bruggeman KF, Kauhausen JA, Guo H, et al. Peptide-Based Scaffolds Support Human Cortical Progenitor Graft Integration to Reduce Atrophy and Promote Functional Repair in a Model of Stroke. Cell Rep 2017; 20(8): 1964-77.
  38. Bogousslavsky J, Caplan LR, Editors. Stroke Syndromes. 2nd Cambridge, UK: Cambridge University Press; 2001.
  39. Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology 1998; 50(2): 341-50.
  40. Jang SH, Choi BY, Chang CH, Kim SH, Chang MC. Prediction of motor outcome based on diffusion tensor tractography findings in thalamic hemorrhage. Int J Neurosci 2013; 123(4): 233-9.
  41. Yeo SS, Chang MC, Kwon YH, Jung YJ, Jang SH. Corticoreticular pathway in the human brain: diffusion tensor tractography study. Neurosci Lett 2012; 508(1): 9-12.
  42. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46(1): 154-9.
  43. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005; 2: 8.
  44. Patel AN, Genovese J. Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy. Stem Cells Cloning 2011; 4: 61-72.
  45. Lin CS, Lin G, Lue TF. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev 2012; 21(15): 2770-8.
  46. Weinger JG, Weist BM, Plaisted WC, Klaus SM, Walsh CM, Lane TE. MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination. Stem Cells 2012; 30(11): 2584-95.
  47. Fainstein N, Ben-Hur T. Brain Region-Dependent Rejection of Neural Precursor Cell Transplants. Front Mol Neurosci 2018; 11: 136.
  48. Yang GY, Betz AL. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994; 25(8): 1658-64.
  49. Daneman R. The blood-brain barrier in health and disease. Ann Neurol 2012; 72(5): 648-72.
  50. Gendron A, Teitelbaum J, Cossette C, Nuara S, Dumont M, Geadah D, et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 2002; 955(1): 85-97.
  51. De Feo D, Merlini A, Laterza C, Martino G. Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection. Curr Opin Neurol 2012; 25(3): 322-33.
  52. Bacigaluppi M, Pluchino S, Peruzzotti-Jametti L, Kilic E, Kilic U, Salani G, et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009; 132(Pt 8): 2239-51.
  53. Chang DJ, Lee N, Park IH, Choi C, Jeon I, Kwon J, et al. Therapeutic potential of human induced pluripotent stem cells in experimental stroke. Cell Transplant 2013; 22(8): 1427-40.
  54. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004; 304(5675): 1338-40.
  55. Ryu S, Lee SH, Kim SU, Yoon BW. Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain. Neural Regen Res 2016; 11(2): 298-304.
  56. Tang Y, Wang J, Lin X, Wang L, Shao B, Jin K, et al. Neural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis. J Cereb Blood Flow Metab 2014; 34(7): 1138-47.
  57. Mine Y, Tatarishvili J, Oki K, Monni E, Kokaia Z, Lindvall O. Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiol Dis 2013; 52: 191-203.
  58. Chu K, Kim M, Jeong SW, Kim SU, Yoon BW. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 2003; 343(2): 129-33.
  59. Ahmadzadeh K, Roshdi Dizaji S, Yousefifard M. Lack of concordance between reporting guidelines and risk of bias assessments of preclinical studies: a call for integrated recommendations. Int J Surg 2023; 109(8): 2557-8.
  60. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323(7304): 101-5.
  61. Jensen MB, Krishnaney-Davison R, Cohen LK, Zhang SC. Injected Versus Oral Cyclosporine for Human Neural Progenitor Grafting in Rats. J Stem Cell Res Ther 2012; Suppl 10: 003.
Current Journal of Neurology
Volume 24, Issue 4
Autumn 2025
Pages 302-318

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us